NEJM SJR and Scopus Metrics: What the Numbers Actually Tell Authors
NEJM sits at the very top of medicine under Scopus as well as JCR, but the real submission question is whether the paper is broad and practice-changing enough.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Quick answer: The New England Journal of Medicine sits at the top of medicine under Scopus-style metrics. Current Scopus-linked browser data reports a 2024 SJR of 19.076, a CiteScore of 96.4, and near-top placement in medicine overall. That confirms extraordinary influence, but the submission decision still depends more on whether the manuscript is broad and practice-changing enough for general medicine than on the metric itself.
The core metric picture
Metric | 2024 value | What it tells you |
|---|---|---|
SJR | 19.076 | Prestige-weighted influence is among the strongest in medicine |
CiteScore | 96.4 | Four-year citation performance is exceptional |
SNIP | 13.467 | Field-normalized impact remains enormous |
Rank | 2 / 668 in medicine | The journal sits near the very top of medicine |
JCR context | Impact factor 78.5 | Web of Science tells the same flagship story |
The useful reading is that NEJM is not only historically prestigious. It remains structurally dominant in the present citation network.
What the metrics actually help with
They help explain why NEJM can stay so selective:
- it reaches one of the broadest and most influential clinical audiences in the world
- it carries unusually strong downstream clinical and institutional signal
- it rewards work that changes practice, not just work that is technically excellent
That is useful when you are choosing between NEJM, another flagship, or a top specialty journal.
What the metrics do not answer
They do not tell you:
- whether the paper is broad enough for general medicine
- whether the clinical consequence is decisive enough
- whether a top specialty audience is still the truer home
- whether the manuscript is only strong within one disease or method lane
Those are still the real editorial questions.
Why the profile matters for authors
At this SJR level, NEJM is buying the strongest possible general-medical visibility. But the number is useful only because it reflects a very specific editorial bar:
- broad clinical consequence
- work that changes practice or thinking
- studies with unusual decisiveness
- papers that matter beyond one specialty room
That is why the metrics should not seduce authors into a bad fit. They are describing the editorial standard, not lowering it.
What should drive the submission decision instead
The better question is whether the manuscript is truly an NEJM paper.
That is why the better next reads are:
If the paper is brilliant but still fundamentally specialty-facing, the metrics do not rescue the mismatch. They only explain why the flagship route remains unforgiving.
Practical verdict
NEJM has extraordinary Scopus-style metrics and remains one of the most powerful journals in medicine. That makes it worth the risk for papers with truly broad clinical consequence.
But the useful takeaway is still fit, not prestige alone. If the manuscript is not clearly practice-shifting for a general-medical audience, the numbers do not help. A free Manusights scan is the fastest way to pressure-test that before submission.
Sources
- 1. NEJM journal browser entry, Wageningen University & Research.
- 2. NEJM journal browser entry, Vrije Universiteit.
- 3. NEJM journal page, Massachusetts Medical Society.
- 4. NEJM author center, Massachusetts Medical Society.
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.